Executive Director, AfroCAB Treatment Access Partnership
Kenly Sikwese is the Executive Director of the AfroCAB Treatment Access Partnership. AfroCAB is a global-, regional- and national-level advocacy network for access to better-quality optimal medicines and newer innovative diagnostics in HIV and co-infections. It operates in 17 African countries and provides healthcare client education on newer and better medicines and diagnostics, including monitoring the HIV treatment and prevention pipeline.
Kenly is a current board member of AVAC and a member of the IAS HIV Vaccine Industry Partnership. He has served as a Unitaid board member, Co-Chair of the UNAIDS 90-90-90 Scientific Advisory Committee, Co-Chair of the UNAIDS Retargeting Technical Committee (90-90-90), and member of the Communities Delegation to the UNAIDS Programme Coordinating Board.
He has served on the World Health Organization (WHO) HIV treatment and other guideline and technical groups since 2010 and the Robert Carr Fund steering committee. Kenly has participated in WHO 2-4 CADOS and is a member of the Optimal ARVs Programme Advisory Committee of WHO, Unitaid, PEPFAR and the Global Fund. He supported implementation of the PLHIV Stigma Index in 12 African countries and Moldova and serves on national, regional and global treatment access technical or advisory groups, as well as research advisory groups and the WHO team that developed the differentiated service delivery model.